Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience.

  • E Kanal
  • Published 2016 in Magnetic resonance imaging


In the past three decades, we have learned much about the potential short-term and long-term safety issues associated with the intravenous administration of gadolinium based contrast agents (GBCAs). Yet, surprisingly, the past few years and even months have been accompanied by new discoveries in this field. This manuscript focuses predominantly on what we… (More)
DOI: 10.1016/j.mri.2016.08.017